Sector: MedicalFOLD (NASDAQ: FOLD)
Headlines
- Amicus Therapeutics Appoints Margaret G. McGlynn, R.Ph., to Board of Directors
Nov 03, 2009 08:02 AM | APD, FOLD, MRK
- Phase Forward to Host Eighth Annual International Users Conference, November 3-5, Boston
Nov 02, 2009 09:01 AM | BMY, FOLD, GENZ, PFWD
- Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates
Oct 29, 2009 04:06 PM | FOLD, SHPGY
- Amicus Therapeutics Announces Third Quarter 2009 Financial Results Release Date
Oct 26, 2009 08:02 AM | FOLD
- Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease
Oct 02, 2009 04:06 PM | FOLD, SHPGY
- Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease
Sep 30, 2009 08:02 AM | FOLD
- Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 14, 2009
Sep 10, 2009 08:01 AM | FOLD, MS
- FDA Calendar Updates: EURX, AMGN, FOLD, ONTY, MEDX
Jun 22, 2009 08:19 PM | AMGN, BMY, EURX, FOLD, MEDX, ONTY
- 10 Extreme Trades On Pending Clinical Trial Results
May 14, 2009 11:42 AM | ARNA, CLDA, FOLD, GNTA, INSM, JAZZ
- Analyst Comments: EOG Resources, Charlotte Russe, VeraSun Energy, Thornburg Mortgage, Amicus Therapeutics
Jul 31, 2008 04:00 PM | CHIC, EOG, FOLD, SHPGY, TMA, VSE
- How Goldman Secretly Bet on the Housing Crash
Nov 01, 2009 01:54 PM | AIG, BLUE, FOLD, GOT, GS, MCO
- How Goldman Secretly Bet on the Housing Crash
Nov 01, 2009 03:52 AM | AIG, BLUE, FOLD, GOT, GS, MCO
- Cylex, Inc. Appoints Brad L. Stewart As Chief Executive Officer and Chairman of the Board
Sep 10, 2009 09:58 AM | DXCM, FOLD, WYE
- StockPreacher.Com Issues Trading Outlook for Keryx Biopharmaceuticals Inc.
Aug 10, 2009 07:51 AM | AMGN, BAX, FOLD, GENZ, KERX
- Amicus Therapeutics Announces Second Quarter 2009 Financial Results
Aug 05, 2009 04:00 PM | FOLD
- Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date
Jul 29, 2009 08:01 AM | FOLD
- Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
Jun 22, 2009 08:02 AM | FOLD
- Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009
May 11, 2009 08:02 AM | FOLD
- Amicus Therapeutics Announces First Quarter 2009 Financial Results
May 07, 2009 04:01 PM | FOLD
- Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date
Apr 30, 2009 08:02 AM | FOLD
- Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
Mar 30, 2009 08:00 AM | FOLD
- Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting
Mar 28, 2009 07:15 AM | FOLD
- Form 3 MCGLYNN MARGARET G For: Oct 28 (10K)
Nov 06, 2009 10:47 AM
- Form 3 John McAdam M For: Oct 28 (10K)
Nov 06, 2009 10:42 AM
- Form 4 BARER SOL J For: Nov 04 (10K)
Nov 05, 2009 03:00 PM
- Form 4 Dentzer James E For: Sep 01 (10K)
Sep 02, 2009 03:13 PM
- Form 4 Dentzer James E For: Aug 01 (10K)
Aug 03, 2009 11:48 AM
- Form 4 Crowley John F For: Jul 14 (10K)
Jul 16, 2009 06:43 PM
- Form 4 Crowley John F For: Jul 09 (10K)
Jul 13, 2009 06:40 PM
- Form 4 Crowley John F For: Jul 06 (10K)
Jul 08, 2009 06:43 PM
- Form 4 Palling David For: Jun 26 (10K)
Jun 30, 2009 02:25 PM
- Form 4 Topper James N For: Jun 10 (10K)
Jun 11, 2009 12:36 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
FOLD
|
Compare to S&P
|
| YTD |
-51.88 %
|
-58.05 %
|
| 4 Weeks |
-54.82 %
|
-55.30 %
|
| 12 Weeks |
-63.11 %
|
-64.03 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 1.67 %
|
|
EPS Growth in Last Year: -63.89 %
|
|
Sales Growth in Last Quarter: -8.36 %
|
|
Sales Growth in Last Quarter: 34.49 %
|
|
